-
RSF says Israel killed highest number of journalists again this year
-
Suns, Spurs win in last tuneups for NBA Cup showdowns
-
Hay to debut for New Zealand as Blundell out of 2nd West Indies Test
-
World record winning streak sets up Morocco for AFCON challenge
-
All Blacks face France in first Test at new Christchurch stadium
-
Cambodia and Thailand clash at border as civilian toll rises
-
South Korea police raid e-commerce giant Coupang over data leak
-
Most markets track Wall St losses as jitters set in ahead of Fed
-
Kenya deploys more police officers to control Haiti's gangs
-
Somali TikToker deported from US for spy kidnapping may be innocent
-
Indian pride as Asiatic lions roar back
-
Australia quick Hazlewood ruled out of Ashes after injury setback
-
Major Japan quake leaves 30 injured
-
Rising living costs dim holiday sparkle for US households
-
Data centers: a view from the inside
-
Long-serving Russian envoy to North Korea dies
-
Reddit says Australia's under-16 social media ban 'legally erroneous'
-
10 reported hurt after big Japan quake, warning of more tremors
-
Jimmy Kimmel extends late night contract for a year
-
Trump says US will allow sale of Nvidia AI chips to China
-
NBA fines Magic's Bane $35,000 for hurling ball at Anunoby
-
Pulisic quick-fire double sends AC Milan top of Serie A
-
Man Utd back on track after Fernandes inspires Wolves rout
-
Syria's Sharaa vows to promote coexistence, one year after Assad's ousting
-
World stocks mostly lower as markets await Fed decision
-
Palmer misses Chelsea's Champions League clash with Atalanta
-
Trump says Europe heading in 'bad directions'
-
Benin hunts soldiers behind failed coup
-
Salah a 'disgrace' for Liverpool outburst: Carragher
-
Peace deal at risk as DR Congo, Burundi slam Rwanda and M23 advances
-
Feminists outraged at video of French first lady's outburst against activists
-
Suspect arrested in theft of Matisse artworks in Brazil: officials
-
Troubled Liverpool host Barnsley in FA Cup third round
-
Slot has 'no clue' whether rebel star Salah has played last Liverpool game
-
Liverpool boss Slot says Salah relationship not broken
-
Powerful 7.6 quake strikes off Japan, tsunami warning lifted
-
100 abducted Nigerian children handed over to state officials
-
Lula orders road map to cut fossil-fuel use in Brazil
-
EU pushes back 2035 combustion-engine ban review to Dec. 16
-
Court will give decision in Sala compensation hearing on March 30
-
Mamdani to swap humble apartment for NY mayor's mansion
-
MSF says conditions for Gaza medics 'as hard as it's ever been' despite truce
-
Sala compensation hearing opens in Cardiff's dispute with Nantes
-
Syria's Sharaa vows to promote coexistence, reconciliation one year after Assad's ousting
-
Club Brugge sack coach in build up to Arsenal clash
-
US residents get free entry to national parks on Trump's birthday
-
Spurs looking into Bissouma conduct after 'laughing gas' report
-
Machado's mother says hopes daughter will collect Nobel in person
-
Salah dropped by Liverpool for Inter Milan clash after outburst
-
Boeing closes takeover of aviation supplier Spirit
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
P.A.Mendoza--AT